The Association between Admission Magnesium Concentrations and Lactic Acidosis in Critical Illness

Journal of Intensive Care Medicine

Volumn 31, Issue 3, 2016, Pages 187-192

  Moskowitz, Ari ^a   Lee, Joon ^b,c   Donnino, Michael W ^a   Mark, Roger ^b   Celi, Leo Anthony ^a,b   Danziger, John ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b Massachusetts Institute of Technology   (United States)

^c UNIVERSITY OF WATERLOO   (Canada)

Author keywords

acidosis; critical illness; lactic; magnesium deficiency; nutritional deficiency; oxidative phosphorylation

Indexed keywords

CREATININE; LACTIC ACID; MAGNESIUM;

ADULT; ALCOHOLISM; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CRITICAL ILLNESS; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HUMAN; HYPOKALEMIA; HYPOMAGNESEMIA; ICD-9; INTENSIVE CARE UNIT; KIDNEY FUNCTION; LACTIC ACIDOSIS; MAGNESIUM BLOOD LEVEL; MAGNESIUM METABOLISM; MAJOR CLINICAL STUDY; MALE; NUTRITIONAL DEFICIENCY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW; SEPSIS; SIMPLIFIED ACUTE PHYSIOLOGY SCORE; TERTIARY CARE CENTER; UNBOUND FRACTION; ACIDOSIS, LACTIC; BLOOD; COMPLICATION; HOSPITALIZATION; MAGNESIUM DEFICIENCY; MIDDLE AGED; MORTALITY; PREDICTIVE VALUE; PROGNOSIS; RISK FACTOR;

ACIDOSIS, LACTIC; CRITICAL ILLNESS; CROSS-SECTIONAL STUDIES; FEMALE; HOSPITALIZATION; HUMANS; INTENSIVE CARE UNITS; MAGNESIUM DEFICIENCY; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84956558114     PISSN: 08850666     EISSN: 15251489     Source Type: Journal    
DOI: 10.1177/0885066614530659     Document Type: Review

References (36)

1. Noronha JL, Matuschak GM,. Magnesium in critical illness: metabolism, assessment, and treatment. Int Care Med. 2002; 28 (6): 667-679.
2. Reinhart RA, Reinhart RA, Desbiens NA,. Hypomagnesemia in patients entering the ICU. Crit Care Med. 1985; 13 (6): 506-507.
3. Ryzen E,. Magnesium deficiency in a medical ICU population. Crit Care Med. 1985; 13 (1): 19-21.
4. Limaye. Hypomagnesemia in critically ill medical patients. J Assoc Physicians. 2011; 59: 19-22.
5. Pham PC, Pham PM, Pham SV, Miller JM, Pham PT,. Hypomagnesemia in patients with type 2 diabetes. Clin J Am Soc Nephrol. 2007; 2 (2): 366-373.
6. Rubiez GJ,. Association of hypomagnesemia and mortality in acutely ill medical patients. Crit Care Med. 1993; 21 (2): 203-209.
7. Chernow B,. Hypomagnesemia in patients in postoperative intensive care. Chest. 1989; 95 (2): 391-397.
8. Soliman HM,. Development of ionized hypomagnesemia is associated with higher mortality rates. Crit Care Med. 2003; 31 (4): 1082-1087.
9. Traviesa DC,. Magnesium deficiency: a possible cause of thiamine refractoriness in Wernicke-Korsakoff encephalopathy. J Neurol Neurosurg Psychiatry. 1974; 37 (8): 959-962.
10. Jung EH, Takeuchi T, Nishino K, Itokawa Y,. Studies on the nature of thiamine pyrophosphate binding and dependency on divalent cations of transketolase from human erythrocytes. Int J Biochem. 1988; 20 (11): 1255-1259.
11. Itokawa Y, Inoue K, Natori Y, Okazaki K, Fujiwara M,. Effect of thiamine on growth, tissue magnesium, thiamine levels and transketolase activity in magnesium deficient rats. J Vitaminol. 1972; 18 (3): 159-64.
12. Manzanares W, Hardy G,. Thiamine supplementation in the critically ill. Curr Opin Clin Nutr Metab Care. 2011; 14 (6): 610-617.
13. Kim JE, Jeon JP, No HC, et al. The effects of magnesium pretreatment on reperfusion injury during living donor liver transplantation. Korean J Anesthesiol. 2011; 60 (6): 408-415.
14. Cinar V, Nizamliolu M, Moulkoc R,. The effect of magnesium supplementation on lactate levels of sportsmen and sedanter. Acta Physiol Hung. 2006; 93 (2-3): 137-144.
15. Saeed M, Villarroel M, Reisner AT, et al. Multiparameter intelligent monitoring in intensive care II (MIMIC-II): a public-access intensive care unit database. Crit Care Med. 2011; 39 (5): 952-960.
16. Shapiro NI, Howell MD, Talmor D, et al. Serum lactate as a predictor of mortality in emergency department patients with infection. Ann Emerg Med. 2005; 45 (5): 524-528.
17. Kroll MH, Elin RJ,. Relationships between magnesium and protein concentrations in serum. Clin Chem. 1985; 31 (2): 244-246.
18. Klahr S, Miller SB,. Acute oliguria. N Engl J Med. 1998; 338 (10): 671-675.
19. Elixhauser A, Steiner C, Harris DR, Coffey RM,. Comorbidity measures for use with administrative data. Med Care 1998; 36 (1): 8-27.
20. Martin GS, Mannino DM, Eaton S, Moss M,. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med. 2003; 348 (16): 1546-1554.
21. Kesteloot H, Joossens JV,. The relationship between dietary intake and urinary excretion of sodium, potassium, calcium and magnesium: Belgian Interuniversity Research on Nutrition and Health. J Hum Hypertens. 1990; 4 (5): 527-533.
22. Larsson SC, Virtamo J, Wolk A,. Potassium, calcium, and magnesium intakes and risk of stroke in women. Am J Epidemiol. 2011; 174 (1): 35-43.
23. Tong GM, Rude RK,. Magnesium deficiency in critical illness. J Intensive Care Med. 2005; 20 (1): 3-17.
24. Huijgen GJ,. Magnesium levels in critically ill patients. What should we measure? Am J Clin Pathol. 2000; 114 (5): 688-695.
25. Escuela MP, Guerra M, Añón JM, et al. Total and ionized serum magnesium in critically ill patients. Int Care Med. 2005; 31 (1): 151-156.
26. Koch SM, Warters RD, Mehlhorn U,. The simultaneous measurement of ionized and total calcium and ionized and total magnesium in intensive care unit patients. J Crit Care. 2002; 17 (3): 203-205.
27. Lanzinger MJ, Moretti EW, Wilderman RF, El-Moalem HE, Toffaletti JG, Moon RE,. The relationship between ionized and total serum magnesium concentrations during abdominal surgery. J Clin Anesth. 2003; 15 (4): 245-249.
28. Resnick LM, Altura BT, Gupta RK, Laragh JH, Alderman MH, Altura BM,. Intracellular and extracellular magnesium depletion in type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia. 1993; 36 (8): 767-770.
29. Tosiello L,. Hypomagnesemia and diabetes mellitus. A review of clinical implications. Arch Intern Med. 1996; 156 (11): 1143-1148.
30. Dzúrik R, Stefíková K, Spustová V, Fetkovská N,. The role of magnesium deficiency in insulin resistance: an in vitro study. J Hypertens Suppl. 1991; 9 (6): S312-S313.
31. Barbagallo M, Dominguez LJ,. Magnesium metabolism in type 2 diabetes mellitus, metabolic syndrome and insulin resistance. Arch Biochem Biophys. 2007; 458 (1): 40-47.
32. Rivlin RS,. Magnesium deficiency and alcohol intake: mechanisms, clinical significance and possible relation to cancer development (a review). J Am Coll Nutr. 1994; 13 (5): 416-423.
33. Weglicki WB, Phillips TM,. Pathobiology of magnesium deficiency: a cytokine/neurogenic inflammation hypothesis. Am J Physiol. 1992; 263: R734-R737.
34. Weglicki WB, Phillips TM, Freedman AM, Cassidy MM, Dickens BF,. Magnesium-deficiency elevates circulating levels of inflammatory cytokines and endothelin. Mol Cell Biochem. 1992; 110 (2): 169-173.
35. Johnson JS, Hand WL, King-Thompson NL,. The role of divalent cations in interactions between lymphokines and macrophages. Cell Immunol. 1980; 53 (2): 236-245.
36. Salem M, Kasinski N, Munoz R, Chernow B,. Progressive magnesium deficiency increases mortality from endotoxin challenge: protective effects of acute magnesium replacement therapy. Crit Care Med. 1995; 23 (1): 108-118.